Infinium Pharmachem Stock Price Analysis and Quick Research Report. Is Infinium Pharmachem an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Infinium Pharmachem. 

• PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Infinium Pharmachem has a PE ratio of 43.4714606410775 which is high and comparatively overvalued.

• Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Infinium Pharmachem has ROA of 6.9468% which is a bad sign for future performance. (Higher values are always desirable.)

• Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Infinium Pharmachem has a Current ratio of 2.2974.

• Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Infinium Pharmachem has a ROE of 10.3617%. (Higher is better)

• Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Infinium Pharmachem has a Debt to Equity ratio of 0.429 which means that the company has low proportion of debt in its capital.

• Sales growth: Infinium Pharmachem has reported revenue growth of 11.8984% which is poor in relation to its growth and performance. 

• Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Infinium Pharmachem for the current financial year is 11.0894012668258%.

• Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Infinium Pharmachem is Rs 0 and the yield is 0%.

• Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Infinium Pharmachem is Rs 5.4346. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Infinium Pharmachem in Ticker for free. Also, one can get the intrinsic value of Infinium Pharmachem by using Valuation Calculators, which are available with a Finology ONE subscription. 

Infinium Pharmachem FAQs

Q1. What is Infinium Pharmachem share price today?
Ans: The current share price of Infinium Pharmachem is Rs 236.25.

Q2. What is the market capitalisation of Infinium Pharmachem?
Ans: Infinium Pharmachem has a market capitalisation of Rs 368.15121 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Infinium Pharmachem?
Ans: The PE ratio of Infinium Pharmachem is 43.4714606410775 and the P/B ratio of Infinium Pharmachem is 3.48261273346404, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Infinium Pharmachem share?
Ans: The 52-week high share price of Infinium Pharmachem is Rs 337, and the 52-week low share price of Infinium Pharmachem is Rs 213.9.

Q5. Does Infinium Pharmachem pay dividends?
Ans: Currently, Infinium Pharmachem does not pay dividends. Dividend yield of Infinium Pharmachem is around 0%.

Q6. What are the face value and book value of Infinium Pharmachem shares?
Ans: The face value of Infinium Pharmachem shares is Rs 10, while the book value per share of Infinium Pharmachem is around Rs 67.837. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Infinium Pharmachem?
Ans: Infinium Pharmachem has a total debt of Rs 45.352715 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Infinium Pharmachem?
Ans: The ROE of Infinium Pharmachem is 10.3617% and ROCE of Infinium Pharmachem is 13.2217%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Infinium Pharmachem a good buy for the long term?
Ans: The Infinium Pharmachem long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Infinium Pharmachem undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Infinium Pharmachem appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Infinium Pharmachem’s financials?
Ans: You can review Infinium Pharmachem’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.